Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1997 1
2007 1
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Update on rosacea and anti-inflammatory-dose doxycycline.
Berman B, Perez OA, Zell D. Berman B, et al. Drugs Today (Barc). 2007 Jan;43(1):27-34. doi: 10.1358/dot.2007.43.1.1025697. Drugs Today (Barc). 2007. PMID: 17315050 Review.
Food and Drug Administration for the treatment of rosacea in the United States is Oracea (CollaGenex Pharmaceuticals Inc., Newtown, PA, USA). Oracea is a 40 mg capsule of doxycycline monohydrate, containing 30 mg immediate-release and 10 mg delayed-release doxycycline
Food and Drug Administration for the treatment of rosacea in the United States is Oracea (CollaGenex Pharmaceuticals Inc., Newtown, PA, USA) …
A lipid-and-polymer-based novel local drug delivery system--BonyPid™: from physicochemical aspects to therapy of bacterially infected bones.
Emanuel N, Rosenfeld Y, Cohen O, Applbaum YH, Segal D, Barenholz Y. Emanuel N, et al. J Control Release. 2012 Jun 10;160(2):353-61. doi: 10.1016/j.jconrel.2012.03.027. Epub 2012 Apr 4. J Control Release. 2012. PMID: 22507550
We developed a novel local drug delivery system based on self-assembly of specific familiar lipids and polymers that encapsulate the desired drug (exemplified by doxycycline). The entrapped doxycycline present in the anhydrous environment of the formulation i …
We developed a novel local drug delivery system based on self-assembly of specific familiar lipids and polymers that encapsulate the desired …
Doxycycline-tricalcium phosphate composite graft facilitates osseous healing in advanced periodontal furcation defects.
Pepelassi EM, Bissada NF, Greenwell H, Farah CF. Pepelassi EM, et al. J Periodontol. 1991 Feb;62(2):106-15. doi: 10.1902/jop.1991.62.2.106. J Periodontol. 1991. PMID: 2027058 Clinical Trial.
The purpose of this study was to compare the effectiveness of a tricalcium phosphate, plaster of paris, and doxycycline composite graft to surgical debridement alone in the treatment of Class II and Class III furcation defects. ...Additionally the plaster served as a vehic …
The purpose of this study was to compare the effectiveness of a tricalcium phosphate, plaster of paris, and doxycycline composite gra …
Administration of doxycycline hydrochloride via drinking water to turkeys under laboratory and field conditions.
Santos MD, Vermeersch H, Remon JP, Schelkens M, De Backer P, Ducatelle R, Haesebrouck F. Santos MD, et al. Poult Sci. 1997 Oct;76(10):1342-8. doi: 10.1093/ps/76.10.1342. Poult Sci. 1997. PMID: 9316108 Free article.
A series of experiments were carried out in order to determine doxycycline hydrochloride (DoxHCl) plasma levels in 6-wk-old turkeys medicated via drinking water containing DoxHCl at a concentration of 250 mg/L under laboratory and field conditions. ...Water consumption und …
A series of experiments were carried out in order to determine doxycycline hydrochloride (DoxHCl) plasma levels in 6-wk-old turkeys m …
The effect of local doxycycline with and without tricalcium phosphate on the regenerative healing potential of periodontal osseous defects in dogs.
Al-Ali W, Bissada NF, Greenwell H. Al-Ali W, et al. J Periodontol. 1989 Oct;60(10):582-90. doi: 10.1902/jop.1989.60.10.582. J Periodontol. 1989. PMID: 2810011
The purpose of this study was to evaluate the clinical and histological effects of high concentration doxycycline on osseous regeneration in adult beagle dogs. Four 5 mm two-wall periodontal osseous defects were created in the premolar and molar area of each quadrant yield …
The purpose of this study was to evaluate the clinical and histological effects of high concentration doxycycline on osseous regenera …